Biobehavioral treatment, disability, and psychological effects of pediatric headache

Scott W Powers1, Frank Andrasik

  • 1Headache Center, Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, OH 45229-3039, USA.

Pediatric Annals
|July 16, 2005
PubMed

Insights

Prompt biobehavioral treatments are crucial for pediatric headache management, improving outcomes and reducing medication needs. Early intervention ensures children experience less pain and disability, preventing long-term issues.

Area of Science:

  • Pediatric Neurology
  • Behavioral Medicine
  • Child Psychology

Background:

  • Headaches are prevalent in children and adolescents, causing significant pain and functional impairment.
  • Untreated pediatric headaches often persist into adulthood, highlighting the need for early intervention.
  • Comprehensive care is essential to prevent long-term consequences of pediatric headaches.

Purpose of the Study:

  • To emphasize the importance of prompt and effective intervention for pediatric headaches.
  • To highlight the central role of biobehavioral treatments in managing pediatric headaches.
  • To advocate for a collaborative approach involving various medical specialists for optimal pediatric headache care.

Main Methods:

  • Integrating biobehavioral treatment components into pediatric headache care plans.
  • Utilizing biofeedback-assisted relaxation training.
  • Promoting adherence to medication and healthy behaviors to reduce headache activity.

Main Results:

  • Biobehavioral treatments lead to better initial clinical outcomes for pediatric headaches.
  • These treatments may reduce the necessity for medication and sustain long-term effects.
  • Improved quality of life and reduced functional disability are key outcomes.

Conclusions:

  • Biobehavioral treatment is foundational for effective pediatric headache care.
  • A multidisciplinary approach involving primary care, child neurologists, and behavioral medicine experts is optimal.
  • Measuring outcomes should include pain parameters, functional disability, and quality of life.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...